Shank3のオリゴメリゼーションは,ポストシナプス密度コンデンサートとシナプス可塑性の物質特性を支配する
Bowen Jia1, Zeyu Shen1, Shihan Zhu1
1School of Life Sciences, Southern University of Science and Technology, Shenzhen, China; Division of Life Science, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China.
Cell
|August 23, 2025
まとめ
生物学的凝縮物は 脳の機能に不可欠な 柔らかいガラス材料を形成します この構造を 破壊すると 記憶が損なわれ 自閉症の行動が起こります
科学分野:
- 細胞生物学
- 神経科学
- バイオ物理学
背景:
- 細胞は,相分離によって形成された 膜のない臓器細胞,または生物学的凝縮物を利用します.
- これらのコンデンサートは 液体から固体まで様々な物質特性を表しますが 規制は不明です
研究 の 目的:
- ポストシナプス密度 (PSD) コンデンサートの材料特性を調査する.
- これらの性質がどのように調節され 神経機能におけるその役割を理解する.
主な方法:
- PSDコンデンサートの再構成 in vitro
- タンパク質ネットワークの浸透と材料の性質の分析
- Shank3変異を持つマウスモデルにおけるシナプス機能と行動の評価.
主要な成果:
- 再構成されたPSD凝縮物は,タンパク質ネットワークの浸透によって柔らかいガラス材料を形成する.
- Shank3 SAMドメインのオリゴメリゼーションの破壊により,PSDコンデンサートが柔らかくなった.
- シャンク3変異を持つマウスでは,シナプス伝達障害,可塑性,自閉症のような行動が観察されました.
結論:
- PSDコンデンサートの物質特性には,シナプス機能,学習,記憶が不可欠です.
- 凝縮物質の特性に影響するShank3変異は,神経学的障害に寄与する.
関連する概念動画
Long-term Potentiation
55.8K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
55.8K
Long-term Depression
2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.6K
Assembly of Signaling Complexes
5.9K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
5.9K
Ligand Binding and Linkage
4.9K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.9K
Chemical Synapses
9.1K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
9.1K
Amyloid Fibrils
9.9K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.9K


